{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:06:14Z","timestamp":1784592374719,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project of the Department of Science and Technology of Changsha","award":["kh2302012"],"award-info":[{"award-number":["kh2302012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16235-4","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:24:51Z","timestamp":1779672291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PAX1 methylation for triage of HR-HPV-positive women: a comparative analysis with cytology and HPV16\/18 genotyping"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9988-4022","authenticated-orcid":false,"given":"Zhengjiao","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2758-7198","authenticated-orcid":false,"given":"Saiping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0019-3861","authenticated-orcid":false,"given":"Hong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7044-0650","authenticated-orcid":false,"given":"Peng","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2444-8453","authenticated-orcid":false,"given":"Hongtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0105-2338","authenticated-orcid":false,"given":"Xiaozhu","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5639-0463","authenticated-orcid":false,"given":"Xing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"2","key":"16235_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, et al. : 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102\u201331.","journal-title":"J Low Genit Tract Dis"},{"issue":"5","key":"16235_CR2","first-page":"321","volume":"70","author":"ETH Fontham","year":"2020","unstructured":"Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70(5):321\u201346.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"16235_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41416-020-0920-9","volume":"123","author":"M Kyrgiou","year":"2020","unstructured":"Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, Kim J, Poljak M, Nieminen P, Sasieni P, et al. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). Br J Cancer. 2020;123(4):510\u20137.","journal-title":"Br J Cancer"},{"key":"16235_CR4","doi-asserted-by":"publisher","unstructured":"Guidelines for cervical cancer screening in China. Chinese Journal of Clinical Obstetrics and Gynecology . 2023;2023\u20137\u201324(4):437\u201342. https:\/\/doi.org\/10.13390\/j.issn.1672-1861.2023.04.029.","DOI":"10.13390\/j.issn.1672-1861.2023.04.029"},{"key":"16235_CR5","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition [M]. World Health Organization, 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572317\/."},{"issue":"9916","key":"16235_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"issue":"1","key":"16235_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12929-019-0520-2","volume":"26","author":"SM Gupta","year":"2019","unstructured":"Gupta SM, Mania-Pramanik J. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis. J Biomed Sci. 2019;26(1):28.","journal-title":"J Biomed Sci"},{"issue":"3","key":"16235_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","volume":"25","author":"DL Loopik","year":"2021","unstructured":"Loopik DL, Bentley HA, Eijgenraam MN, IntHout J, Bekkers RLM, Bentley JR. The Natural History of Cervical Intraepithelial Neoplasia Grades 1, 2, and 3: A Systematic Review and Meta-analysis. J Lower Genit Tract Dis. 2021;25(3):221\u201331.","journal-title":"J Lower Genit Tract Dis"},{"issue":"11","key":"16235_CR9","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-17-0534","volume":"26","author":"GA Stanczuk","year":"2017","unstructured":"Stanczuk GA, Baxter GJ, Currie H, Forson W, Lawrence JR, Cuschieri K, Wilson A, Patterson L, Govan L, Black J, et al. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16\/18 Genotyping, Cytology, and p16\/Ki-67 Cytoimmunochemistry. Cancer Epidemiol Biomarkers Prev. 2017;26(11):1629\u201335.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"16235_CR10","doi-asserted-by":"publisher","unstructured":"Ouh YT, Kim HY, Yi KW, Lee NW, Kim HJ, Min KJ. Enhancing cervical cancer screening: review of p16\/Ki-67 dual staining as a promising triage strategy. diagnostics (Basel Switzerland). 2024;14(4):451. https:\/\/doi.org\/10.3390\/diagnostics14040451.","DOI":"10.3390\/diagnostics14040451"},{"issue":"3","key":"16235_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ijc.30090","volume":"139","author":"RM Ebisch","year":"2016","unstructured":"Ebisch RM, de Kuyper-de Ridder GM, Bosgraaf RP, Massuger LF, IntHout J, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, et al. The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples. Int J Cancer. 2016;139(3):691\u20139.","journal-title":"Int J Cancer"},{"issue":"6","key":"16235_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrc3728","volume":"14","author":"RD Steenbergen","year":"2014","unstructured":"Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14(6):395\u2013405.","journal-title":"Nat Rev Cancer"},{"key":"16235_CR13","doi-asserted-by":"publisher","first-page":"200288","DOI":"10.1016\/j.tvr.2024.200288","volume":"18","author":"M Molano","year":"2024","unstructured":"Molano M, Machalek DA, Phillips S, Tan G, Garland SM, Hawkes D, Balgovind P, Haqshenas R, Badman SG, Bolnga J, et al. DNA methylation at individual CpG-sites of EPB41L3, HTERT and FAM19A4 are useful for detection of cervical high-grade squamous intraepithelial lesions (HSIL) or worse: Analysis of individual CpG-sites outperforms averaging. Tumour virus Res. 2024;18:200288.","journal-title":"Tumour virus Res"},{"issue":"1","key":"16235_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cmi.2020.03.018","volume":"27","author":"FJ Vink","year":"2021","unstructured":"Vink FJ, Lissenberg-Witte BI, Meijer C, Berkhof J, van Kemenade FJ, Siebers AG, Steenbergen RDM, Bleeker MCG, Heideman DAM. FAM19A4\/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort. Clin Microbiol Infect. 2021;27(1):125. e121-125 e126.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"16235_CR15","doi-asserted-by":"publisher","first-page":"e081282","DOI":"10.1136\/bmjopen-2023-081282","volume":"14","author":"M Molano","year":"2024","unstructured":"Molano M, Machalek DA, Tan G, Garland S, Balgovind P, Haqshenas G, Munnull G, Phillips S, Badman SG, Bolnga J, et al. Performance of CADM1, MAL and miR124-2 methylation as triage markers for early detection of cervical cancer in self-collected and clinician-collected samples: an exploratory observational study in Papua New Guinea. BMJ Open. 2024;14(6):e081282.","journal-title":"BMJ Open"},{"issue":"5","key":"16235_CR16","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/ijc.35289","volume":"156","author":"L Verhoef","year":"2025","unstructured":"Verhoef L, Bleeker MCG, Polman N, Kroon KR, Steenbergen RDM, Ebisch RMF, Melchers WJG, Bekkers RLM, Molijn AC, van Kemenade F, et al. Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation and\/or HPV genotyping in HPV positive women with low-grade cytology from a population-based Dutch primary HPV screening trial. Int J Cancer. 2025;156(5):1065\u201373.","journal-title":"Int J Cancer"},{"key":"16235_CR17","doi-asserted-by":"publisher","unstructured":"Vieira-Baptista P, Costa M, Hippe J, Sousa C, Schmitz M, Silva AR, Hansel A, Preti M. Evaluation of host gene methylation as a triage test for HPV-positive women-a cohort study. J Low Genit Tract Dis. 2024;28(4):326\u201331. https:\/\/doi.org\/10.1097\/LGT.0000000000000830.","DOI":"10.1097\/LGT.0000000000000830"},{"issue":"1","key":"16235_CR18","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1186\/s12885-024-13126-4","volume":"24","author":"H Tao","year":"2024","unstructured":"Tao H, Yu F, Yang L, Pei X, Mao S, Fan X. Comparing the performance of DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer in women with high-risk human papillomavirus-positive status in a gynecologic outpatient population. BMC Cancer. 2024;24(1):1352.","journal-title":"BMC Cancer"},{"key":"16235_CR19","doi-asserted-by":"publisher","unstructured":"Schreiberhuber L, Barrett JE, Wang J, Redl E, Herzog C, Vavourakis CD, Sundstr\u00f6m K, Dillner J, Widschwendter M. Cervical cancer screening using DNA methylation triage in a real-world population. Nat Med. 2024;30:2251\u20137. https:\/\/doi.org\/10.1038\/s41591-024-03014-6.","DOI":"10.1038\/s41591-024-03014-6"},{"key":"16235_CR20","doi-asserted-by":"publisher","first-page":"l240","DOI":"10.1136\/bmj.l240","volume":"364","author":"M Rebolj","year":"2019","unstructured":"Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K, Smith J, Evans C, Giles T, Frew V, et al. Primary cervical screening with high risk human papillomavirus testing: observational study. BMJ. 2019;364:l240.","journal-title":"BMJ"},{"issue":"28","key":"16235_CR21","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2217\/fon-2023-0226","volume":"19","author":"L Yang","year":"2023","unstructured":"Yang L, Tao H, Lin B, He X, Chen Y, Fan X. Utilization of PAX1 methylation test for cervical cancer screening of non-HPV16\/18 high-risk HPV infection in women. Future Oncol. 2023;19(28):1917\u201327.","journal-title":"Future Oncol"},{"key":"16235_CR22","doi-asserted-by":"publisher","unstructured":"Chan KKL, Liu SS, Lau LSK, Ngu SF, Chu MMY, Tse KY, Cheung ANY, Ngan HYS. PAX1\/SOX1 DNA methylation versus cytology and HPV16\/18 genotyping for the triage of high-risk HPV-positive women in cervical cancer screening: retrospective analysis of archival samples. BJOG: an international journal of obstetrics and gynaecolog. 2024;132:197\u2013204. https:\/\/doi.org\/10.1111\/1471-0528.17965.","DOI":"10.1111\/1471-0528.17965"},{"key":"16235_CR23","doi-asserted-by":"publisher","unstructured":"Kong L, Xiao X, Wu H, You Y, Jin X, Liou Y, Liu P, Lang J, Li L. Triage performance of DNA methylation for women with high-risk human papillomavirus infection. Oncologist. 2024;10;30(3):oyae324. https:\/\/doi.org\/10.1093\/oncolo\/oyae324.","DOI":"10.1093\/oncolo\/oyae324"},{"key":"16235_CR24","doi-asserted-by":"crossref","unstructured":"Chang CL, Ho SC, Su YF, Juan YC, Huang CY, Chao AS, Hsu ZS, Chang CF, Fwu CW, Chang TC. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan. Gynecol Oncol. 2021.","DOI":"10.1016\/j.ygyno.2021.02.011"},{"issue":"6","key":"16235_CR25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/ijc.33314","volume":"148","author":"AT Ram\u00edrez","year":"2021","unstructured":"Ram\u00edrez AT, S\u00e1nchez GI, Nedjai B, Agudelo MC, Brentnall AR, Cuschieri K, Casta\u00f1eda KM, Cuzick J, Lorincz AT. Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country. Int J Cancer. 2021;148(6):1383\u201393.","journal-title":"Int J Cancer"},{"issue":"1","key":"16235_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1186\/s12885-024-12696-7","volume":"24","author":"M Huang","year":"2024","unstructured":"Huang M, Wang T, Li M, Qin M, Deng S, Chen D. Evaluating PAX1 methylation for cervical cancer screening triage in non-16\/18 hrHPV-positive women. BMC Cancer. 2024;24(1):913.","journal-title":"BMC Cancer"},{"issue":"8","key":"16235_CR27","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.xcrm.2023.101143","volume":"4","author":"P Zhu","year":"2023","unstructured":"Zhu P, Xiong J, Yuan D, Li X, Luo L, Huang J, Wang B, Nie Q, Wang S, Dang L, et al. ZNF671 methylation test in cervical scrapings for cervical intraepithelial neoplasia grade 3 and cervical cancer detection. Cell Rep Med. 2023;4(8):101143.","journal-title":"Cell Rep Med"},{"issue":"1","key":"16235_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12916-024-03267-5","volume":"22","author":"D Cao","year":"2024","unstructured":"Cao D, Yang Z, Dong S, Li Y, Mao Z, Lu Q, Xu P, Shao M, Pan L, Han X, et al. PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study. BMC Med. 2024;22(1):55.","journal-title":"BMC Med"},{"issue":"1","key":"16235_CR29","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.1038\/s41598-019-45477-5","volume":"9","author":"PH Su","year":"2019","unstructured":"Su PH, Lai HC, Huang RL, Chen LY, Wang YC, Wu TI, Chan MWY, Liao CC, Chen CW, Lin WY, et al. Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer. Sci Rep. 2019;9(1):9195.","journal-title":"Sci Rep"},{"issue":"1","key":"16235_CR30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1186\/s12885-024-12920-4","volume":"24","author":"H Luo","year":"2024","unstructured":"Luo H, Lian Y, Tao H, Zhao Y, Wang Z, Zhou J, Zhang Z, Jiang S. Relationship between p16\/ki67 immunoscores and PAX1\/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women. BMC Cancer. 2024;24(1):1171.","journal-title":"BMC Cancer"},{"issue":"1","key":"16235_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/ijc.23519","volume":"123","author":"HC Lai","year":"2008","unstructured":"Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan MW, Chu TY, Sun CA, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer. 2008;123(1):161\u20137.","journal-title":"Int J Cancer"},{"issue":"10","key":"16235_CR32","first-page":"1471","volume":"61","author":"LY Kong","year":"2015","unstructured":"Kong LY, Du W, Wang L, Yang Z, Zhang HS. PAX1 Methylation Hallmarks Promising Accuracy for Cervical Cancer Screening in Asians: Results from a Meta-Analysis. Clin Lab. 2015;61(10):1471\u20139.","journal-title":"Clin Lab"},{"issue":"2","key":"16235_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ijc.33815","volume":"150","author":"C Banila","year":"2022","unstructured":"Banila C, Lorincz AT, Scibior-Bentkowska D, Clifford GM, Kumbi B, Beyene D, Wheeler CM, Cuschieri K, Cuzick J, Nedjai B. Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study. Int J Cancer. 2022;150(2):290\u2013302.","journal-title":"Int J Cancer"},{"issue":"5","key":"16235_CR34","doi-asserted-by":"publisher","first-page":"ofac013","DOI":"10.1093\/ofid\/ofac013","volume":"9","author":"K Fu","year":"2022","unstructured":"Fu K, Lei M, Wu LS, Shi JC, Yang SY, Yang WQ, Xu JY, Kang YN, Yang ZY, Zhang X, et al. Triage by PAX1 and ZNF582 Methylation in Women With Cervical Intraepithelial Neoplasia Grade 3: A Multicenter Case-Control Study. Open Forum Infect Dis. 2022;9(5):ofac013.","journal-title":"Open Forum Infect Dis"},{"key":"16235_CR35","doi-asserted-by":"publisher","unstructured":"Lu Y, Wu H, Fu K, Shen Y, Li L, Liao Z, Liu Y, Kang Y, Zhang Y. PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16\/18-positive women undergoing colposcopy. Clin Epigenetics. 2024;16:77. https:\/\/doi.org\/10.1186\/s13148-024-01691-1.","DOI":"10.1186\/s13148-024-01691-1"},{"issue":"1","key":"16235_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/1471-0528.17577","volume":"131","author":"SA Rauf","year":"2024","unstructured":"Rauf SA, Zehra SA, Shah HH. Beyond P16\/Ki67 dual-stain cytology: Exploring alternative biomarkers for diagnosing cervical cancer and its precursors. BJOG. 2024;131(1):115\u20136.","journal-title":"BJOG"},{"issue":"11","key":"16235_CR37","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/ijc.33778","volume":"149","author":"S Salta","year":"2021","unstructured":"Salta S, Maia-Moco L, Estevao-Pereira H, Sequeira JP, Vieira R, Bartosch C, Petronilho S, Monteiro P, Sousa A, Baldaque I, et al. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study. Int J Cancer. 2021;149(11):1916\u201325.","journal-title":"Int J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16235-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16235-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16235-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:36:58Z","timestamp":1784590618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16235-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16235"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16235-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was in compliance with the Helsinki Declaration. Ethical approval was obtained from the Research and Clinical Trial Ethics Committee, Changsha Hospital for Maternal & Child Health Care (No: EC-20230726-02). All patients provided written informed consent to participate in this trial.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"874"}}